Company NPS Pharmaceuticals, Inc.
Equities
US62936P1030
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | NPS Pharmaceuticals : Shire confident on 2015 after NPS deal, binge-eating drug approval | RE |
2015 | NPS Pharmaceuticals : Shire shares jump as drug approval vindicates $5.2 billion NPS purchase | RE |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,581,155 | 108,074,845 ( 99.53 %) | 0 | 99.53 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.73% | 21.97B | |
-4.64% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- Stock
- Company NPS Pharmaceuticals, Inc.